The Patent Finder

Alfacell Corporation

Also on record
Records under this name other than patents Alfacell Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Alfacell Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,229,824Ribonucleases and Methods of Making Them Recombinantly
Formerly held
Term ended
Term ended May 24, 2024 · High confidence
Term endedTerm ended May 24, 2024High confidence
US 7,763,449Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long
Formerly held
Term ended
Term ended Aug 27, 2023 · High confidence
Term endedTerm ended Aug 27, 2023High confidence
US 7,442,535Fusion Protein Incorporating a Cysteinized Ribonuclease
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,442,536Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,473,542Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,556,951Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,556,952Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of a Known Amino Acid Sequence and an Initial N-Terminal Residue
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,556,953Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,585,654Nucleic Acid Encoding Cysteinized Ribonuclease to Which a Targeting Moiety Can Be Conjugated
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
US 7,585,655Nucleic Acid Encoding a Fusion Protein Incorporating a Cysteinized Ribonuclease
Formerly held
Term ended
Term ended Jul 17, 2023 · High confidence
Term endedTerm ended Jul 17, 2023High confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited